Aimcare Pharmaceuticals Private Limited

Aimcare Pharmaceuticals Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U52100DL2016PTC307766 Incorporated 01 November 2016 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2025
₹2.86 Lakh
▼ 84% YoY
Net loss · FY 2025
₹13,154
Net margin -4.6%
EBITDA · FY 2025
-₹13,154
EBITDA margin -4.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Aimcare Pharmaceuticals Private Limited

Data last updated:

Aimcare Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 01 November 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52100DL2016PTC307766.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Jiomax Healthcare Private Limited. It is led by directors Rajeev Kumar and Adarsh Rajpoot.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor Rz – F – 15 Gali No. 5 Mahavir Enclave 1, New Delhi, Delhi, India – 110045.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.86 Lakh, a decline of 84% compared to the previous year. For the same year it recorded a net loss of ₹13,154 (net margin -4.6%) and EBITDA of -₹13,154 (EBITDA margin -4.6%). Revenue has declined at a compounded annual rate (CAGR) of 46% over three years and 32% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U52100DL2016PTC307766
Registration Number 307766
Incorporation Date 01 November 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Aimcare Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1st Floor Rz – F – 15 Gali No. 5 Mahavir Enclave 1, New Delhi, Delhi, India – 110045
  • Industry
    Trading, Wholesale, Other Wholesale

To see the full contact details of Aimcare Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Aimcare Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Aimcare Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Aimcare Pharmaceuticals Private Limited, buy the company report.

Financials of Aimcare Pharmaceuticals Private Limited

FY 2025 filings available

Aimcare Pharmaceuticals Private Limited reported revenue of ₹2.86 Lakh (down 84% YoY) for FY 2025.

Revenue · FY 2025
₹2.86 Lakh ▼ 84%
Net loss · FY 2025
₹13,154 margin -4.6%
EBITDA · FY 2025
-₹13,154 margin -4.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 84%
3 years · compounded
▼ 46%
5 years · compounded
▼ 32%
EBITDA CAGR growth
3 years · compounded
▼ 134%
5 years · compounded
▼ 41%

Revenue has declined at a compounded annual rate (CAGR) of 32% over five years, including a 84% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹13,154
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹13,154
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-4.6%
Net Profit Margin-4.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Aimcare Pharmaceuticals Private Limited, buy the company report.

Board of directors of Aimcare Pharmaceuticals Private Limited

Aimcare Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajeev KumarDirector01 Nov 201610 Years 0 MonthsCurrent
Adarsh RajpootDirector19 Apr 20233 Years 6 MonthsCurrent

Auditor

Aimcare Pharmaceuticals Private Limited is audited by GARG NIDHI & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
GARG NIDHI & ASSOCIATESFY 2017018568C

Shareholding

The shareholding of Aimcare Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Aimcare Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aimcare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Aimcare Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Aimcare Pharmaceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Harish Kumar ceased to be Director on 24 May 2024.

AGM
Aimcare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aimcare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Harish Kumar ceased to be Director.
Ceased
Saroj ceased to be Director.
Ceased
Vishaw Dev Rajput ceased to be Director.
Appointed
Adarsh Rajpoot was appointed as Director.
Appointed
Rajeev Kumar was appointed as Director.
Incorporation
01 Nov 2016
Aimcare Pharmaceuticals Private Limited was registered on 01 Nov 2016 with Roc Delhi & aged 10 years 2 days as per MCA records.

Frequently asked questions

Aimcare Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 01 November 2016 (10+ years old) and is registered under CIN U52100DL2016PTC307766.

Aimcare Pharmaceuticals has 2 current directors:

The latest financial statements of Aimcare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The CIN (Corporate Identification Number) of Aimcare Pharmaceuticals is U52100DL2016PTC307766. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aimcare Pharmaceuticals was incorporated on 01 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.

Harish Kumar ceased to be Director on 24 May 2024. Saroj ceased to be Director on 24 May 2024. Vishaw Dev Rajput ceased to be Director on 24 May 2024. Aimcare Pharmaceuticals has 5 board changes on record in total.

The registered office of Aimcare Pharmaceuticals is at 1st Floor Rz – F – 15 Gali No. 5 Mahavir Enclave 1, New Delhi, Delhi, India – 110045.

Aimcare Pharmaceuticals operates in the trading industry, in the wholesale segment.

The compliance status of Aimcare Pharmaceuticals is compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.

Yes. Aimcare Pharmaceuticals was formerly known as Jiomax Healthcare Private Limited.